• 2025
  Blaise Lafoux, Gustave Fourcaud, Jimmy Hortion, Laura Soyer, Alexandra Journeaux, Clara Germain, Stéphanie Reynard, Hadrien Cousseau, Clémentine Larignon, Natalia Pietrosemoli, Séverine Croze, Joël Lachuer, Emeline Perthame, Sylvain Baize, Expansion of myeloid suppressor cells and suppression of Lassa virus-specific T cells during fatal Lassa fever, PLoS Pathogens, 2025, 21 (4), pp.e1013111. ⟨10.1371/journal.ppat.1013111⟩.
• 2024
  Hortion J, Perthame E, Lafoux B, Soyer L, Reynard S, Journeaux A, Germain C, Lopez-Maestre H, Pietrosemoli N, Baillet N, Croze S, Rey C, Legras-Lachuer C, Baize S, Fatal Lassa fever in cynomolgus monkeys is associated with systemic viral dissemination and inflammation., PLoS Pathog 2024 Dec; 20(12): e1012768.
• 2024
  Jill-Léa Ramassamy, Ahidjo Ayouba, Guillaume Thaurignac, Chanceline Bilounga Ndongo, Patrick Nnuka, Edouard Betsem, Richard Njouom, Eitel Mpoudi Ngole, Jessica Vanhomwegen, Damien Hoinard, Patrick England, Alexandra Journeaux, Caroline Picard, Damien Thomas, Delphine Pannetier, Sylvain Baize, Eric Delaporte, Martine Peeters, Antoine Gessain, High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population, Journal of Infectious Diseases, 2024, pp.jiae399. ⟨10.1093/infdis/jiae399⟩.
• 2023
  Collados Rodríguez M, Maillard P, Journeaux A, Komarova AV, Najburg V, David RS, Helynck O, Guo M, Zhong J, Baize S, Tangy F, Jacob Y, Munier-Lehmann H, Meurs EF, Novel Antiviral Molecules against Ebola Virus Infection., Int J Mol Sci 2023 Sep; 24(19): .
• 2023
  Lafoux B, Baillet N, Picard C, Fourcaud G, Borges-Cardoso V, Reynard S, Journeaux A, Germain C, Perthame E, Mateo M, Hortion J, Carnec X, Pietrosemoli N, Moroso M, Lacroix O, Jourjon O, Barron S, Vallve A, Duthey A, Jacquot F, Barrot L, Dirheimer M, Raoul H, Nougier C, Baize S, Hemostasis defects underlying the hemorrhagic syndrome caused by Mammarenaviruses in a cynomolgus macaque model., Blood 2023 Sep; (): .
• 2023
  Mateo M, Reynard S, Pietrosemoli N, Perthame E, Journeaux A, Noy K, Germain C, Carnec X, Picard C, Borges-Cardoso V, Hortion J, Lopez-Maestre H, Regnard P, Fellmann L, Vallve A, Barron S, Jourjon O, Lacroix O, Duthey A, Dirheimer M, Daniau M, Legras-Lachuer C, Carbonnelle C, Raoul H, Tangy F, Baize S, Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys., Nat Commun 2023 Mar; 14(1): 1352.
• 2023
  Reynard S, Carnec X, Picard C, Borges-Cardoso V, Journeaux A, Mateo M, Germain C, Hortion J, Albrecht L, Perthame E, Pietrosemoli N, Vallvé A, Barron S, Duthey A, Lacroix O, Jourjon O, Moroso M, Fellmann L, Moreau PH, Daniau M, Legras-Lachuer C, Dirheimer M, Carbonnelle C, Raoul H, Baize S, , A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primates., Nat Microbiol 2023 Jan; 8(1): 64-76.
• 2022
  Mateo M, Hortion J, Perthame E, Picard C, Reynard S, Journeaux A, Germain C, Carnec X, Baillet N, Borges-Cardoso V, Pietrosemoli N, Vallve A, Barron S, Jourjon O, Lacroix O, Duthey A, Dirheimer M, Daniau M, Legras-Lachuer C, Jouvion G, Carbonnelle C, Raoul H, Baize S, , Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys., Virulence 2022 12; 13(1): 654-669.
• 2022
  Merabet O, Pietrosemoli N, Perthame E, Armengaud J, Gaillard JC, Borges-Cardoso V, Daniau M, Legras-Lachuer C, Carnec X, Baize S, , Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus., Viruses 2022 Mar; 14(3): .
• 2021
  Mateo M, Reynard S, Journeaux A, Germain C, Hortion J, Carnec X, Picard C, Baillet N, Borges-Cardoso V, Merabet O, Vallve A, Barron S, Jourjon O, Lacroix O, Duthey A, Dirheimer M, Jouvion G, Moreau PH, Fellmann L, Carbonnelle C, Raoul H, Tangy F, Baize S, A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains., Sci Transl Med 2021 Jun; 13(597): .
• 2021
  Baillet N, Reynard S, Perthame E, Hortion J, Journeaux A, Mateo M, Carnec X, Schaeffer J, Picard C, Barrot L, Barron S, Vallve A, Duthey A, Jacquot F, Boehringer C, Jouvion G, Pietrosemoli N, Legendre R, Dillies MA, Allan R, Legras-Lachuer C, Carbonnelle C, Raoul H, Baize S, , Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques., Commun Biol 2021 Jan; 4(1): 27.
• 2019
  Mateo M, Reynard S, Carnec X, Journeaux A, Baillet N, Schaeffer J, Picard C, Legras-Lachuer C, Allan R, Perthame E, Hillion KH, Pietrosemoli N, Dillies MA, Barrot L, Vallve A, Barron S, Fellmann L, Gaillard JC, Armengaud J, Carbonnelle C, Raoul H, Tangy F, Baize S, , Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot., Sci Transl Med 2019 10; 11(512): .
• 2019
  Reynard S, Journeaux A, Gloaguen E, Schaeffer J, Varet H, Pietrosemoli N, Mateo M, Baillet N, Laouenan C, Raoul H, Mullaert J, Baize S, Immune parameters and outcomes during Ebola virus disease, JCI Insight 2019 Jan;4(1).
• 2015
  Sagui E, Janvier F, Baize S, Foissaud V, Koulibaly F, Savini H, Maugey N, Aletti M, Granier H, Carmoi T, Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement, Clin. Infect. Dis. 2015 Nov;61(10):1627-8.
• 2015
  Baize S, Towards deep insight into Ebola virus disease, Lancet Infect Dis 2015 Sep;15(9):991-992.
• 2015
  Baize S, Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus, Curr Opin Virol 2015 Feb;10:70-6.
• 2015
  Reusken C, Niedrig M, Pas S, Anda P, Baize S, Charrel R, Di Caro A, Drosten C, Fernandez-Garcia MD, Franco L, Gunther S, Leparc-Goffart I, Martina B, Pannetier D, Papa A, Sanchez-Seco MP, Vapalahti O, Koopmans M, Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014, J. Clin. Virol. 2015 Jan;62:124-34.
• 2014
  Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, Berthet N, Blinkova O, Brister JR, Clawson AN, Fair J, Gabriel M, Garry RF, Gire SK, Goba A, Gonzalez JP, Günther S, Happi CT, Jahrling PB, Kapetshi J, Kobinger G, Kugelman JR, Leroy EM, Maganga GD, Mbala PK, Moses LM, Muyembe-Tamfum JJ, N'Faly M, Nichol ST, Omilabu SA, Palacios G, Park DJ, Paweska JT, Radoshitzky SR, Rossi CA, Sabeti PC, Schieffelin JS, Schoepp RJ, Sealfon R, Swanepoel R, Towner JS, Wada J, Wauquier N, Yozwiak NL, Formenty P, Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014, Viruses 2014 Nov;6(11):4760-99.
• 2014
  Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y, Ebola: should we consider influenza vaccination?, Lancet 2014 Dec;384(9959):2023-4.
• 2014
  Reynard S, Russier M, Fizet A, Carnec X, Baize S, Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response, J. Virol. 2014 Dec;88(23):13923-7.
• 2014
  Russier M, Reynard S, Carnec X, Baize S, The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses, J. Virol. 2014 Dec;88(23):13811-20.
• 2014
  Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S, Emergence of Zaire Ebola virus disease in Guinea, N. Engl. J. Med. 2014 Oct;371(15):1418-25.
• 2014
  Reynes JM, Razafindralambo NK, Lacoste V, Olive MM, Barivelo TA, Soarimalala V, Heraud JM, Lavergne A, Anjozorobe hantavirus, a new genetic variant of Thailand virus detected in rodents from Madagascar, Vector Borne Zoonotic Dis. 2014 Mar;14(3):212-9.
• 2014
  Pannetier D, Reynard S, Russier M, Carnec X, Baize S, Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever, PLoS Negl Trop Dis 2014;8(1):e2637.
• 2013
  Macé G, Feyeux C, Mollard N, Chantegret C, Audia S, Rebibou JM, Spagnolo G, Bour JB, Denoyel GA, Sagot P, Reynes JM, Severe Seoul hantavirus infection in a pregnant woman, France, October 2012, Euro Surveill. 2013;18(17):20464.
• 2012
  Russier M, Pannetier D, Baize S, Immune responses and Lassa virus infection, Viruses 2012 Nov;4(11):2766-85.
• 2011
  Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M, Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages, J. Virol. 2011 Nov;85(22):12093-7.
• 2011
  Leroy EM, Gonzalez JP, Baize S, Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa, Clin. Microbiol. Infect. 2011 Jul;17(7):964-76.
• 2010
  Baize S, Towards broad protection against Ebolaviruses, Future Microbiol 2010 Oct;5(10):1469-73.
• 2006
  Baize S, Pannetier D, Faure C, Marianneau P, Marendat I, Georges-Courbot MC, Deubel V, Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages, Microbes Infect. 2006 Apr;8(5):1194-202.
• 2004
  Pannetier D, Faure C, Georges-Courbot MC, Deubel V, Baize S, Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection, J. Virol. 2004 Oct;78(19):10516-24.